Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have no symptoms and whose condition is considered medically stable
- People aged between 18 and 75 years
- People of any gender
- People with blood pressure that is not fully controlled (while already on stable blood pressure medication), with a systolic blood pressure reading between 135 and 160 mmHg as measured by a 24-hour blood pressure monitor worn on the arm
- People who are willing to avoid changes to their medications for up to 24 weeks (and ideally one year)
- People who are willing to sign a written consent form agreeing to take part
- People who are willing to have 24-hour blood pressure monitoring and ultrasound scans of the blood vessels at three time points: at the start, at 24 weeks, and preferably again at one year
Who may not be able to join:
- People for whom wearing a 24-hour blood pressure monitor may not be safe or appropriate, such as those with a heart rhythm condition called atrial fibrillation (confirm with trial site)
- People with severe osteoarthritis of the knee
- People whose high blood pressure is known to be caused by another underlying medical condition
- People who are pregnant or breastfeeding
- People currently being treated for or diagnosed with cancer
- People with serious heart conditions such as unstable chest pain, or significant kidney or liver problems
- People whose blood pressure rises above 160 mmHg (systolic) at the 24-week point and who would need a medication change to manage it
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kam Sang Woo, Chinese University of Hong Kong
Phone: +852 26474966
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension; The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension; The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.